This new technology could one day significantly expand the market for gene-editing biotechs.
There's more to young biopharma companies than their numbers, but those numbers are still an important part of each ...
Learn how gene editing is transforming sickle cell disease treatment and why expanding access to younger children matters.
As genome editing therapies move through clinical trials to regulatory approval, scientists continue the quest for the holy ...
A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...
Cancer cells excel at evading detection, but subtle chemical differences set them apart from healthy cells. Now, a team of scientists from Wageningen University & Research and Van Andel Institute has ...
A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...
Researchers have revealed new details about the CRISPR-Cas5-HNH/Cascade complex, a variant of the type I-E CRISPR-Cas system, providing insights into its DNA recognition and cleavage mechanisms. The ...
Researchers are investigating the potential of CRISPR in relation to Down syndrome.
New research shows it’s possible to edit the DNA of human embryos with more precision. But scientists warn it’s still not ...
Nobel Prize winner and CRISPR DNA-editing pioneer Jennifer A. Doudna, PhD, spoke Thursday at Fred Hutch Cancer Center in Seattle. Her lecture kicked off the President’s Seminar series, presented by ...